Soliris (eculizumab)


Generic Name: eculizumab (E kue LIZ oo mab)
Brand Names: Soliris 

Generic name: ECULIZUMAB 300mg in 30mL
Dosage form: injection, solution, concentrate

Manufacturer: Alexion Pharmaceuticals
HCPCS Code: J1300
HCPCS Descriptor: Injection, eculizumab, 10 mg
Vial strength: 300 mg per 30 ml
HCPCS units per vial: 30 units
Price per 30mL/300mg vial: $1,000




Buy Cheap Soliris Online without prescription legit

Buy Cheap Soliris Online is a monoclonal antibody. Eculizumab binds to proteins in the blood that can destroy red blood cells in people with genetic conditions that affect the natural defenses of red blood cells. Soliris is used to prevent the breakdown of red blood cells in people with paroxysmal nocturnal hemoglobinuria (PNH). Soliris is used to treat atypical hemolytic uremic syndrome (aHUS), a rare chronic blood disease. Soliris is also used to treat generalized myasthenia gravis (gMG) in adult patients. You must  understand the risks and benefits of taking this medication.


Soliris 300 mg/30 ml, 30 milliliters, Solution

Buy Cheap Soliris Online is used to treat a certain blood disorder (paroxysmal nocturnal hemoglobinuria). This disorder can cause a decrease in red blood cells (anemia). This medication helps to block the decrease in red blood cells and can improve the symptoms of anemia (e.g., tiredness, shortness of breath) and decrease the need for blood transfusions. This medication may also be used to treat a certain immune system disorder (atypical Hemolytic Uremic Syndrome). It helps to prevent blood clots caused by this disorder. Eculizumab is also used to treat a certain muscle condition (generalized Myasthenia Gravis). Buy Cheap Soliris Online may help to improve symptoms of this condition (such as difficulty swallowing, trouble breathing).


What is the drug Soliris Eculizumab used for 

It binds to proteins in the blood that can destroy red blood cells in people with genetic conditions that affect the natural defenses of red blood cells. It is used to prevent the breakdown of red blood cells in people with paroxysmalnocturnal hemoglobinuria (PNH).

How is Eculizumab administered 

It is supplied as a 300-mg, single-use vial. It should be administered as an IV infusion and must be diluted to a final concentration of 5 mg/mL prior toadministration. DO NOT ADMINISTER AS AN IV PUSH OR BOLUS INJECTION. Eculizumab, sold under the trade name Soliris, is a medication used to treatparoxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS). It is a humanized monoclonal antibody functioning as a terminal complement inhibitor.

Administer the it by intravenous infusion over 35 minutes in adults and 1 to 4 hours in pediatric patients via gravity feed, a syringe-type pump, or an infusion pump. Admixed solutions of Soliris Eculizumab are stable for 24 h at 2-8° C (36-46° F) and at room temperature. If an adverse reaction occurs during the administration of Soliris, the infusion may be slowed or stopped at the discretion of the physician. If the infusion is slowed, the total infusion time should not exceed two hours in adults. Monitor the patient for at least one hour following completion of the infusion for signs or symptoms of an infusion reaction. For inquiries on other products visit our SHOP .


Side Effects

Get emergency medical help if you have signs of an allergic reaction to Soliris: hives; chest pain, difficult breathing; feeling like you might pass out; swelling of your face, lips, tongue, or throat. Signs of allergic reaction may occur while you are receiving your injection. 


Buy SOLIRIS (Eculizumab) Online

Soliris is a pharmaceutical used to treat an orphan disease, atypical hemolytic-uremic syndrome (aHUS). An orphan disease by definition effects 200,000 people or less in the United States. aHUS is a genetic disease, where blood elements (cells and platelets) are destroyed by the immune system, and their debris interferes with kidney function resulting in high blood pressure and ultimately renal failure. Before 2011 treatment consisted of transfusions to replace the blood elements lost, use of blood pressure medications to control hypertension and as necessary plasmapheresis. Plasmapheresis clears the blood of the debris that injures the kidney. Plasmapheresis, like dialysis, involves being ‘hooked’ to a machine for 3 to 4 hours as the blood is rinsed. But in 2011, the FDA approved Soliris now “recommended as first-line therapy in both children and adults with a confirmed or strongly suspected diagnosis of aHUS.”


Please follow and like us:


There are no reviews yet.

Be the first to review “Soliris (eculizumab)”

Your email address will not be published. Required fields are marked *